OsmiR159 reportedly influences BPH resistance by regulating its target; repression of OsGAMYBL2 by OsmiR159 inhibits GS3 gene expression, thus increasing BPH resistance [12]. The gene discussed is DNAJC21; the disease is benign prostatic hyperplasia.